Skip to main content

Animations

MJFF Publications

1041 - 1050 of 6466 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2012
  • 2011
  • 2023
  • 2022
  • 2023
  • 2023
  • 2019
  • Summary Details
    OPEN
    Title: The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/ene.14032
    Citation Count: 29
  • Summary Details
    OPEN
    Title: A combined miRNA–piRNA signature to detect Alzheimer’s disease
    Journal Name: Translational Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41398-019-0579-2
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Nonlinear Z‐score modeling for improved detection of cognitive abnormality
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.08.003
    Citation Count: 26
  • Summary Details
    OPEN
    Title: BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2012.84
    Citation Count: 103
  • Summary Details
    OPEN
    Title: BAX inhibitor‐1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00775
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13570
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Preface to the 4th MDS Video Challenge Case Supplement for Movement Disorders Clinical Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13832
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networks
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.120276
    Citation Count: 29
  • Summary Details
    OPEN
    Title: A specific amino acid motif ofHLA-DRB1mediates risk and interacts with smoking history in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1821778116
    Citation Count: 80
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.